MOTS-c: Dosage, Protocol, and Research Guide
Mitochondrial-derived peptide that regulates metabolism and enhances exercise capacity
Mechanism
16-amino acid peptide encoded in mitochondrial DNA that activates AMPK pathway, improves insulin sensitivity, promotes fat oxidation, and enhances mitochondrial biogenesis.
Protocol at a glance
| Starting dose | 5mg |
|---|---|
| Maintenance dose | 5-10mg |
| Maximum dose | 10mg |
| Frequency | 3 times weekly |
| Typical duration | 4-8 weeks |
| Route | Subcutaneous |
| Injection site | Abdomen |
| Timing | Pre-workout or morning |
Side effects
- Minimal reported
- Possible mild nausea
Contraindications
- Pregnancy
- Type 1 diabetes
Protocol notes
- Improves metabolic flexibility
- Enhances exercise performance
- May protect against age-related metabolic decline
- Activates cellular stress resistance pathways
- Promotes fat loss while preserving muscle
Frequently asked questions
What is MOTS-c and how does it work?
MOTS-c is a 16-amino acid mitochondrial-derived peptide that activates the AMPK pathway, a key regulator of cellular energy metabolism. This activation improves insulin sensitivity, promotes fat oxidation, and enhances mitochondrial biogenesis—essentially improving how your cells produce energy. MOTS-c also activates cellular stress resistance pathways, which may help protect against age-related metabolic decline. By enhancing metabolic flexibility, the peptide allows your body to more efficiently switch between fuel sources and optimize energy production during both rest and exercise.
Is MOTS-c legal to use?
MOTS-c is not FDA-approved for human use and remains a research compound. Legal status varies by jurisdiction. In the United States, MOTS-c exists in a regulatory grey area—it is not scheduled as a controlled substance, but it is not approved as a therapeutic drug. Many suppliers market it as research-only material, and availability may be restricted in some areas. Any use should be discussed with a qualified healthcare provider who can advise on applicable regulations in your location and ensure proper clinical oversight.
What is the recommended dosing protocol for MOTS-c?
The standard MOTS-c protocol involves a starting dose of 5mg administered subcutaneously three times weekly. After initial tolerance assessment, the dose can be increased to a maintenance range of 5-10mg, with 10mg serving as the maximum recommended dose. The peptide is typically administered into the abdomen, with timing optimized for pre-workout or morning administration. A standard protocol duration is 4-8 weeks, allowing adequate time for cellular adaptation and mitochondrial biogenesis to occur. Individual protocols should always be established under medical supervision.
Can MOTS-c be stacked with other peptides?
Research on MOTS-c stacking and combination protocols remains limited. While some practitioners explore combining MOTS-c with other metabolism-supporting peptides, specific data on synergistic effects, interactions, or optimal stacking combinations is not well-established in published literature. Any decision to stack MOTS-c with other peptides should be made in consultation with a healthcare provider experienced in peptide protocols, who can assess individual health markers and monitor outcomes appropriately.
What side effects does MOTS-c cause?
Side effects associated with MOTS-c are minimal and rarely reported. The primary side effect noted in research and user reports is possible mild nausea, which typically resolves with continued use or dose adjustment. Most individuals tolerate MOTS-c well when administered correctly. The contraindications to MOTS-c use include pregnancy and Type 1 diabetes, reflecting metabolic considerations specific to these populations. Anyone with existing health conditions or concerns about tolerance should discuss use with their healthcare provider.
How does MOTS-c affect exercise performance?
MOTS-c enhances exercise performance by improving mitochondrial biogenesis and increasing ATP production efficiency. This translates to improved exercise capacity, better endurance, and faster recovery between training sessions. The peptide's ability to promote fat oxidation while preserving muscle tissue makes it particularly relevant for individuals seeking to maintain strength while optimizing body composition. Athletes often report improved aerobic capacity and enhanced energy availability during training. Effects typically emerge over the 4-8 week protocol duration as mitochondrial adaptations accumulate.
What lab markers should I monitor while using MOTS-c?
Research on MOTS-c specific biomarkers remains limited. However, given that MOTS-c improves insulin sensitivity and promotes fat oxidation, baseline and periodic monitoring of insulin levels, fasting glucose, lipid panels, and body composition may provide useful tracking metrics. AMPK activation—MOTS-c's primary mechanism—is associated with improved metabolic health markers. Working with a healthcare provider to establish baseline bloodwork before beginning MOTS-c and repeating testing at 4-8 weeks can help assess individual response and safety.
What is a cycling protocol for MOTS-c?
A typical MOTS-c cycling approach involves 4-8 weeks of consistent use (three injections weekly at 5-10mg) followed by a break period. The break allows cells to reset and prevents potential desensitization to the peptide. Specific cycling duration beyond the standard 4-8 week protocol window and appropriate break intervals are areas where research on MOTS-c remains limited. Practitioners vary in their cycling approaches, and individualized protocols should be established with a qualified healthcare provider based on response markers, goals, and health status.
More Longevity & Anti-Aging peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.